Biotech Stock Review

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.

First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?

Dalrada (DFCO) Removes Shell Company Status.

LIVE QUOTE SAN DIEGO, Nov. 6, 2020 SAN DIEGO , Nov. 6,...
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...
Mark Washo, Aphex Biocleanse

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...

PITTSFORD, N.Y., Nov. 12, 2020 PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
OMNIQ

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
Hapbee

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...

Kevin Harrington Presentation. (Video)

The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...

Hepion Pharma Doses First Patient in the ‘AMBITION’ Clinical Trial.

Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH.

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...